IGF2R Antikörper (FITC)
Kurzübersicht für IGF2R Antikörper (FITC) (ABIN641534)
Target
Alle IGF2R Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse Anti-Human CD222 [+FITC]
-
Produktmerkmale
- Adhesion Molecule/Cell Surface
-
-
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibody
IGF2R Reaktivität: Human, Non-Human Primate WB, FACS, IP Wirt: Maus Monoclonal MEM-238 unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibodyIGF2R Reaktivität: Human WB, IHC Wirt: Kaninchen Monoclonal unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) (AA 424-529) antibodyIGF2R Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, FACS, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) (AA 2327-2491) antibodyIGF2R Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibodyIGF2R Reaktivität: Human WB, IF Wirt: Kaninchen Monoclonal unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) (AA 160-311) antibodyIGF2R Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 4F1G1 unconjugated
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibody (FITC)IGF2R Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MEM-238 FITC
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibody (PE)IGF2R Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MEM-238 PE
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) antibody (APC)IGF2R Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MEM-238 APC
anti-Insulin-Like Growth Factor 2 Receptor (IGF2R) (AA 2441-2490) antibodyIGF2R Reaktivität: Human, Maus, Ratte IHC, ELISA, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Flow Cytometry
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- IGF2R (Insulin-Like Growth Factor 2 Receptor (IGF2R))
-
Andere Bezeichnung
- CD222
Target
-
